Experience

SHEPHERD

• United States
• Biotechnology Research
• 1 - 100 Employee

• Data Analyst

  • Jul 2022 - Present

  As a DELVE team member, I conduct computational and literature based research to support DELVE’s pharmaceutical and patient focused applications. My work spans broad topics within cancer biology with an emphasis on intelligent drug combination design, integration of DNA sequencing data, and computational evaluations of the hallmarks of cancer. As a DELVE team member, I conduct computational and literature based research to support DELVE’s pharmaceutical and patient focused applications. My work spans broad topics within cancer biology with an emphasis on intelligent drug combination design, integration of DNA sequencing data, and computational evaluations of the hallmarks of cancer.



Massachusetts General Hospital

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Research Assistant

  • Sep 2019 - Jul 2022

  As a member of the Rabkin Lab in the Brain Tumor Research Center, I analyzed NGS data to identify polymorphisms between the expected sequence and actual sequence of an oncolytic HSV-1 vector as well as identify genetic differences between isolates displaying phenotypic differences. Additionally, I completed an independent research project which culminated in my undergraduate thesis entitled, “Construction and analysis of oncolytic herpes simplex virus type 1 for the treatment of glioblastoma”. As a member of the Rabkin Lab in the Brain Tumor Research Center, I analyzed NGS data to identify polymorphisms between the expected sequence and actual sequence of an oncolytic HSV-1 vector as well as identify genetic differences between isolates displaying phenotypic differences. Additionally, I completed an independent research project which culminated in my undergraduate thesis entitled, “Construction and analysis of oncolytic herpes simplex virus type 1 for the treatment of glioblastoma”.



SHEPHERD

• United States
• Biotechnology Research
• 1 - 100 Employee

• Biology Intern

  • May 2020 - Mar 2021

  As an intern, I compiled information on rare cancers and on drug candidates to support machine learning projects. I also leveraged previously identified synthetic dosage lethality pairs to identify novel therapeutic targets for specific molecularly defined indications. As an intern, I compiled information on rare cancers and on drug candidates to support machine learning projects. I also leveraged previously identified synthetic dosage lethality pairs to identify novel therapeutic targets for specific molecularly defined indications.



Winship Cancer Institute of Emory University

• United States
• Hospitals and Health Care
• 400 - 500 Employee

• Summer Intern

  • May 2019 - Aug 2019

  As a member of the Goldsmith Lab, I planned and executed drug assays to evaluate the efficacy of three small molecules against established neuroblastoma cell lines. As a member of the Goldsmith Lab, I planned and executed drug assays to evaluate the efficacy of three small molecules against established neuroblastoma cell lines.



Massachusetts Eye and Ear

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Research Assistant

  • Jan 2019 - May 2019

  As a member of the Chodosh Lab, I utilized qPCR to evaluate the immune response to adenovirus in ocular cells and contributed to a publication on this topic. As a member of the Chodosh Lab, I utilized qPCR to evaluate the immune response to adenovirus in ocular cells and contributed to a publication on this topic.